Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (6153)	1/24/1999 4:56:00 PM
From: Dauntless	Read Replies (2) \| Respond to of 7041

VLAD - Prove it <<SGP=a large pharma that wanted to get into the ED game and now regrets picking ZONA and Vasomax as it's drug to represent as an ED cure.>> How are you going to explain the continued investment by SGP in the filings for approvals and commercial launches around the world? Their launch of the product in Mexico represented a MAJOR increase in their commitment - in expenses, reputation and product liability. Ditto for England, Europe, New Zealand, etc, etc..... Funny - SGP had access to most, if not all, of the clinical trial results before they signed up - certainly they knew enough to assess the basic efficacy. I guess they're just not as "respectable" a company as Merck, huh.? Tell you what, you offer some real proof to back up your claim that SGP "regrets" anything about their ZONA & Vasomax involvement and then we'll have something to discuss.